Journal
BIOMEDICINES
Volume 8, Issue 12, Pages -Publisher
MDPI
DOI: 10.3390/biomedicines8120550
Keywords
electronegative LDL; LDL(-); L5 LDL; oxidized LDL; oxLDL; lectin-like oxLDL receptor-1; LOX-1; dyslipidemia; endothelial dysfunction; atherosclerosis; cardiovascular disease
Categories
Funding
- Kaohsiung Medical University [KMU-TC108A03-0]
- Kaohsiung Medical University Hospital [KMUH-M109017]
- Kaohsiung Municipal Ta-Tung Hospital [kmtth-101-001]
- Taiwan Ministry of Science and Technology [MOST109-2320-B-037-028, 109-2628-B-037-010]
Ask authors/readers for more resources
Dysregulation of glucose and lipid metabolism increases plasma levels of lipoproteins and triglycerides, resulting in vascular endothelial damage. Remarkably, the oxidation of lipid and lipoprotein particles generates electronegative lipoproteins that mediate cellular deterioration of atherosclerosis. In this review, we examined the core of atherosclerotic plaque, which is enriched by byproducts of lipid metabolism and lipoproteins, such as oxidized low-density lipoproteins (oxLDL) and electronegative subfraction of LDL (LDL(-)). We also summarized the chemical properties, receptors, and molecular mechanisms of LDL(-). In combination with other well-known markers of inflammation, namely metabolic diseases, we concluded that LDL(-) can be used as a novel prognostic tool for these lipid disorders. In addition, through understanding the underlying pathophysiological molecular routes for endothelial dysfunction and inflammation, we may reassess current therapeutics and might gain a new direction to treat atherosclerotic cardiovascular diseases, mainly targeting LDL(-) clearance.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available